Infusion into the mother of adrenocorticotrophin during late normal pregnancy was accompanied by rises or falls in the urinary excretion of oestrone, oestradiol and oestriol. A similar variable pattern was found when the subjects infused were receiving regular pharmacological doses of glucocorticosteroid (i.e. when maternal adrenal function was reduced) or were carrying anencephalic foetuses (i.e. when foetal adrenal function was reduced). Similar infusion of a substantial quantity of androst-5-en-17-on-3β-yl sulphate (DHAS) was accompanied by rises in oestrogen excretion by normal subjects. The rises were large compared with basal levels, but small (a few per cent) compared with the amount of DHAS infused. The changes in a pregnancy with anencephaly were within the range of the normal subjects. It is concluded that maternal DHAS plays little part in placental oestrogen synthesis, and that some control of oestrogen synthesis from DHAS occurs by the placenta itself.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 0 | 0 | 0 |
PDF Downloads | 1 | 0 | 0 |